K-pop

Say My Name's Shu Yi Suspends Activities Due to Health Issues… Group to Continue as a 7-Member Unit for the Time Being

Agency: "Will Focus on Recovery for the Time Being" The timing of the return will be determined at a later date

YUN GI BACK
2026-07-31 16:11:08
[Edaily Starin YUN GI BACK Reporter] Sui, a member of the group SAY MY NAME, will temporarily suspend activities due to health reasons.
SAY MY NAME’s Shui (Photo: Incode)

On the 31st, their agency, Incode Entertainment, announced via a fan platform, “After continuously monitoring Shui’s health condition and holding thorough discussions with the artist herself, we have decided to suspend all activities for the time being so she can focus on her recovery.”
Accordingly, SAY MY NAME will continue their activities as a 7-member group for the time being.
The agency stated, “The timing of her return to activities will be decided carefully, prioritizing the artist’s recovery,” adding, “We sincerely apologize once again to our fans for causing concern, and we ask that you please send Shui your warm support and encouragement.”
Seimaineim is a girl group launched last October by Incode Entertainment, founded by Kim Jae-joong. After debuting as a 7-member group, they expanded to their current 8-member lineup when Shui joined in August of last year.

Economy

Corporation

IT·Science

Economy

Concerns Over a Slowdown in AI Investment Following the U.S. Midterm Elections… 'Warning Signs' for South Korean Semiconductors as China Catches Up

“China’s Changxin Memory is catching up at an astonishing pace. Having rapidly dominated the general-purpose semiconductor market, it is now challenging the high-specification semiconductor and high-b…
2026-11-13 17:18:35

Corporation

Burdened by Raw Material Costs and Voluntary Retirement Expenses… Pulmuone Corporate’s Third-Quarter Operating Profit Down 89.6%

Pulmuone Corporate’s operating profit for the third quarter of this year fell to one-tenth of the level recorded in the same period last year. Although sales increased, profitability in its domestic b…
2026-11-13 16:40:27

IT·Science

HANDOK Inc.: Partner Company’s Rare Hypoglycemia Treatment Set to Draw Attention This Year… Results of External Collaboration Put to the Test

Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…
2026-11-13 15:42:02